Tirzep Injection 10 mg/0.5 ml contains Tirzepatide, a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist designed for adults with type 2 diabetes mellitus (T2DM). By simultaneously targeting both GIP and GLP-1 pathways, Tirzepatide enhances glucose-dependent insulin secretion, suppresses glucagon release, slows gastric emptying, and reduces appetite.

This intermediate dose is used after titration from lower doses (2.5 mg, 5 mg, or 7.5 mg) to provide optimal glycemic control while maintaining tolerability and improving weight management.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Tirzep Injection is indicated for:

• Adults with type 2 diabetes mellitus requiring better glycemic control
• Adjunct therapy for patients not adequately controlled with diet and exercise
• Combination therapy with oral antihyperglycemic medications if necessary
• Patients seeking metabolic benefits including weight management

Mechanism of Action

Tirzepatide works through dual receptor agonism:

• GIP receptor activation: Enhances insulin secretion in response to elevated blood glucose.
• GLP-1 receptor activation: Suppresses glucagon release, slows gastric emptying, and reduces appetite.

These actions lead to improved fasting and postprandial blood glucose levels, reduction in HbA1c, and support for weight management.

Dosage and Administration

• Administered subcutaneously once weekly.
• Dose escalation: Start at 2.5 mg, increase to 5 mg, 7.5 mg, and then 10 mg under physician guidance.
• Inject into the abdomen, thigh, or upper arm; rotate injection sites to reduce local reactions.
• Do not mix with other injectable drugs.
• Adhere strictly to the prescribed schedule for optimal glycemic control.

Benefits

• Effective reduction in HbA1c for type 2 diabetes
• Supports weight management as part of comprehensive diabetes care
• Convenient once-weekly dosing enhances adherence
• Improves fasting and postprandial glucose levels
• Dual GIP/GLP-1 action provides superior metabolic control compared to single-agent therapy

Side Effects

Common side effects:

• Nausea, vomiting, or diarrhea
• Constipation
• Injection site reactions (redness, swelling, or itching)
• Decreased appetite
• Mild headache or fatigue

Serious but rare side effects:

• Hypoglycemia, particularly with insulin or sulfonylureas
• Pancreatitis (persistent severe abdominal pain)
• Allergic reactions, including anaphylaxis
• Thyroid C-cell tumors (rare; contraindicated in patients with personal or family history of medullary thyroid carcinoma)

Seek immediate medical attention if severe reactions or pancreatitis symptoms occur.

Precautions and Warnings

• Not indicated for type 1 diabetes or diabetic ketoacidosis.
• Monitor patients with a history of pancreatitis or gastrointestinal disorders.
• Pregnancy and breastfeeding should only use under medical supervision.
• Regular blood glucose monitoring is essential, especially with combination therapy.
• Use cautiously in patients with severe renal or hepatic impairment.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Drug Interactions

Tirzep Injection may interact with:

• Other antidiabetic medications (risk of hypoglycemia)
• Oral drugs with narrow therapeutic indices (due to delayed gastric emptying)
• Medications affecting gastrointestinal motility

Always inform your healthcare provider about all medications and supplements being taken.

Storage

• Store in a refrigerator at 2–8°C; do not freeze
• Protect from light and heat
• Keep out of reach of children
• Do not use after the expiration date
• Follow package instructions for usage period after opening.